Antibodies Against Membrane Protein Targets – Part 1

Paid

As the industry increasingly shifts its attention to biologics, more attention is being paid to the prospect of developing biotherapeutics against membrane-bound targets. For these large target classes, biologics offer improved selectivity, an alternative for targets with known function that have not been amenable to small molecule drugs and the po

26-27 September 2023

Healthcare

Lead Generation Strategies

Paid

Cambridge Healthtech Institute’s annual Lead Generation Strategies conference illuminates the latest approaches used by medicinal, biophysical and computational chemists to discover and develop small molecules (and now slightly larger molecules that retain potential for oral bioavailability) into drug candidates. Join us to hear case studies applyi

27-28 September 2023

Healthcare